Immunic Dividends

IMUX -  USA Stock  

USD 8.61  0.25  2.99%

Preferred Dividends Income Statement Impact is likely to drop to about 8.7 M in 2021.
Immunic's past performance could be the main factor of why investors trade Immunic stock today. Investors should clearly understand every aspect of the Immunic dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Immunic's past dividend schedule and payout information as well as to compare it to related equities in the form of a graph and calendar. Immunic dividends can also provide a clue to the current valuation of Immunic.

Immunic Dividends 

 
Refresh
Investing in stocks that pay dividends, such as stock of Immunic, is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Immunic must own a stock before its ex-dividend date to receive its next dividend.
Use comma (,) to separate each symbol. If not specified, the peers will be provided automatically based on Macroaxis sector classification standards for immunic. To filter out specific equities, please toggle its corresponding legend item. Please see Risk vs Return Analysis.
Last ReportedProjected for 2021
Preferred Dividends Income Statement Impact10.5 M8.7 M

Specify up to 10 symbols:

Is Immunic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. If investors know Immunic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Immunic Preferred Dividends Income Statement Impact Over Time

Today, most investors in Immunic Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Immunic's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's preferred dividends income statement impact growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Immunic preferred dividends income statement impact as a starting point in their analysis.
Income statement item reflecting dividend payments to preferred stockholders. Subtracted from Net Income to Parent Net Income to obtain Net Income to Common Stockholders Net Income Common Stock.
 Preferred Dividends Income Statement Impact 
Share
      Timeline 

Your potential positions

Your current and potential positions are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification; find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

My Equities

My Current Equities and Potential Positions

IMUX - USA Stock
Immunic
IMUX
Immunic Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
LocationGermany
ExchangeNASDAQ Exchange
USD 8.61
Please see Risk vs Return Analysis. Note that the Immunic information on this page should be used as a complementary analysis to other Immunic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Immunic Stock analysis

When running Immunic price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go